4015 fundamentals
An in-depth look to JAMJOOM PHARMACEUTICALS FACTORY CO. operating, investing, and financing activities
4015 free cash flow for Q4 24 is 143.24 M SAR. For 2024, 4015 free cash flow was 206.47 M SAR and operating cash flow was 263.3 M SAR.
Q2 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SAR
Q2 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM